UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Diagnosis of fusion genes using targeted RNA sequencing

Nature communications, 2019-03, Vol.10 (1), p.1388-1388, Article 1388

2019

Volltextzugriff (PDF)

Cancer Patient Experience of Uncertainty While Waiting for Genome Sequencing Results

Frontiers in psychology, 2021-04, Vol.12, p.647502-647502

2021

Volltextzugriff (PDF)

High frequency of germline TP53 mutations in a prospective adult-onset sarcoma cohort

PloS one, 2013-07, Vol.8 (7), p.e69026-e69026

2013

Volltextzugriff (PDF)

Clinical implications of genomics for cancer risk genetics

The lancet oncology, 2015-06, Vol.16 (6), p.e303-e308

2015

Volltextzugriff (PDF)

Advanced Cancer Patient Knowledge of and Attitudes towards Tumor Molecular Profiling

Translational oncology, 2020-09, Vol.13 (9), p.100799-100799, Article 100799

2020

Volltextzugriff (PDF)

Author Correction: Diagnosis of fusion genes using targeted RNA sequencing

Nature communications, 2020-04, Vol.11 (1), p.1810-1810, Article 1810

2020

Volltextzugriff (PDF)

The PiGeOn project: protocol for a longitudinal study examining psychosocial, behavioural and ethical issues and outcomes in cancer tumour genomic profiling

BMC cancer, 2018-04, Vol.18 (1), p.389-389, Article 389

2018

Volltextzugriff (PDF)

The PiGeOn project: protocol of a longitudinal study examining psychosocial and ethical issues and outcomes in germline genomic sequencing for cancer

BMC cancer, 2018-04, Vol.18 (1), p.454-454, Article 454

2018

Volltextzugriff (PDF)

Psychosocial morbidity in TP53 mutation carriers: is whole-body cancer screening beneficial?

Familial cancer, 2017-07, Vol.16 (3), p.423-432

2017

Volltextzugriff (PDF)

POT1 clinical risk management is an open question

European journal of human genetics : EJHG, 2024-08

2024

Volltextzugriff (PDF)

Identification of novel sarcoma risk genes using a two-stage genome wide DNA sequencing strategy in cancer cluster families and population case and control cohorts

BMC medical genetics, 2019-05, Vol.20 (1), p.69-69, Article 69

2019

Volltextzugriff (PDF)

Smad and p38 MAP Kinase-mediated Signaling of Proteoglycan Synthesis in Vascular Smooth Muscle

The Journal of biological chemistry, 2008-03, Vol.283 (12), p.7844-7852

2008

Volltextzugriff (PDF)

Imatinib inhibits vascular smooth muscle proteoglycan synthesis and reduces LDL binding in vitro and aortic lipid deposition in vivo

Journal of cellular and molecular medicine, 2010-06, Vol.14 (6b), p.1408-1418

2010

Volltextzugriff (PDF)

Li-Fraumeni syndrome: cancer risk assessment and clinical management

Nature reviews. Clinical oncology, 2014-05, Vol.11 (5), p.260-271

2014

Volltextzugriff (PDF)

Suramin inhibits PDGF-stimulated receptor phosphorylation, proteoglycan synthesis and glycosaminoglycan hyperelongation in human vascular smooth muscle cells

Journal of pharmacy and pharmacology, 2013-07, Vol.65 (7), p.1055-1063

2013

Volltextzugriff (PDF)

My Research Results: a program to facilitate return of clinically actionable genomic research findings

European journal of human genetics : EJHG, 2022-03, Vol.30 (3), p.363-366

2022

Volltextzugriff (PDF)

Therapeutic implications of germline genetic findings in cancer

Nature reviews. Clinical oncology, 2019-06, Vol.16 (6), p.386-396

2019

Volltextzugriff (PDF)

Myelodysplastic syndrome and multiple solid tumours in an individual with compound heterozygous deleterious FANCM variants: A case report and review of the literature

British journal of haematology, 2023-11, Vol.203 (3), p.481-484

2023

Volltextzugriff (PDF)

A signal-seeking Phase 2 study of olaparib and durvalumab in advanced solid cancers with homologous recombination repair gene alterations

British journal of cancer, 2023-08, Vol.129 (3), p.475-485

2023

Volltextzugriff (PDF)

Vascular wall proteoglycan synthesis and structure as a target for the prevention of atherosclerosis

Vascular health and risk management, 2007, Vol.3 (1), p.117-124

2007

Volltextzugriff (PDF)

Translating genomic risk into an early detection strategy for sarcoma

Genes chromosomes & cancer, 2019-02, Vol.58 (2), p.130-136

2019

Volltextzugriff (PDF)

Surveillance recommendations for patients with germline TP53 mutations

Current opinion in oncology, 2015-07, Vol.27 (4), p.332-337

2015

Volltextzugriff (PDF)

From ownership to custodianship of tumor biopsy tissue in genomic testing: a mixed methods study of patient views

The oncologist (Dayton, Ohio), 2024-05, Vol.29 (9), p.e1169

2024

Volltextzugriff (PDF)

Effectively communicating comprehensive tumor genomic profiling results: Mitigating uncertainty for advanced cancer patients

Patient education and counseling, 2022-02, Vol.105 (2), p.452-459

2022

Volltextzugriff (PDF)

Platelet-derived Growth Factor Differentially Regulates the Expression and Post-translational Modification of Versican by Arterial Smooth Muscle Cells through Distinct Protein Kinase C and Extracellular Signal-regulated Kinase Pathways

The Journal of biological chemistry, 2010-03, Vol.285 (10), p.6987-6995

2010

Volltextzugriff (PDF)

1 – 25 von 97

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(95)
Mit Volltextzugriff
(88)

Publikationsform

Artikel
(96)
Buchkapitel
(1)

Sprache

Englisch
(97)
Japanisch
(7)

Erscheinungsjahr

n.n

Thema

Science & Technology
(65)
Life Sciences & Biomedicine
(63)
Humans
(53)
Oncology
(30)
Cancer
(27)
Genomics
(21)
Female
(19)
Male
(17)
Muscle, Smooth, Vascular - Metabolism
(15)
Genetics & Heredity
(14)
Adult
(13)
Genetic Predisposition To Disease
(13)
Muscle, Smooth, Vascular - Drug Effects
(13)
Neoplasms - Genetics
(13)
Sarcoma
(12)
Middle Aged
(11)
Proteoglycans - Biosynthesis
(11)
Animals
(10)
Genetics
(10)
Mutation
(10)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Diagnosis of fusion genes using targeted RNA sequencing

Cancer Patient Experience of Uncertainty While Waiting for Genome Sequencing Results

High frequency of germline TP53 mutations in a prospective adult-onset sarcoma cohort

Clinical implications of genomics for cancer risk genetics

Advanced Cancer Patient Knowledge of and Attitudes towards Tumor Molecular Profiling

Author Correction: Diagnosis of fusion genes using targeted RNA sequencing

The PiGeOn project: protocol for a longitudinal study examining psychosocial, behavioural and ethical issues and outcomes in cancer tumour genomic profiling

The PiGeOn project: protocol of a longitudinal study examining psychosocial and ethical issues and outcomes in germline genomic sequencing for cancer

Psychosocial morbidity in TP53 mutation carriers: is whole-body cancer screening beneficial?

POT1 clinical risk management is an open question

Identification of novel sarcoma risk genes using a two-stage genome wide DNA sequencing strategy in cancer cluster families and population case and control cohorts

Smad and p38 MAP Kinase-mediated Signaling of Proteoglycan Synthesis in Vascular Smooth Muscle

Imatinib inhibits vascular smooth muscle proteoglycan synthesis and reduces LDL binding in vitro and aortic lipid deposition in vivo

Li-Fraumeni syndrome: cancer risk assessment and clinical management

Suramin inhibits PDGF-stimulated receptor phosphorylation, proteoglycan synthesis and glycosaminoglycan hyperelongation in human vascular smooth muscle cells

My Research Results: a program to facilitate return of clinically actionable genomic research findings

Therapeutic implications of germline genetic findings in cancer

Myelodysplastic syndrome and multiple solid tumours in an individual with compound heterozygous deleterious FANCM variants: A case report and review of the literature

A signal-seeking Phase 2 study of olaparib and durvalumab in advanced solid cancers with homologous recombination repair gene alterations

Vascular wall proteoglycan synthesis and structure as a target for the prevention of atherosclerosis

Translating genomic risk into an early detection strategy for sarcoma

Surveillance recommendations for patients with germline TP53 mutations

From ownership to custodianship of tumor biopsy tissue in genomic testing: a mixed methods study of patient views

Effectively communicating comprehensive tumor genomic profiling results: Mitigating uncertainty for advanced cancer patients

Platelet-derived Growth Factor Differentially Regulates the Expression and Post-translational Modification of Versican by Arterial Smooth Muscle Cells through Distinct Protein Kinase C and Extracellular Signal-regulated Kinase Pathways

Suchergebnisse filtern